WATSON 395 50 0 .5 (Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg)

Pill with imprint WATSON 395 50 0 .5 is Green, Elliptical / Oval and has been identified as Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg. It is supplied by Watson Pharmaceuticals.

Naloxone/pentazocine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Naloxone/pentazocine 0.5 mg / 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 395 50 0 .5

Naloxone Hydrochloride and Pentazocine Hydrochloride

Imprint

WATSON 395 50 0 .5

Strength

0.5 mg / 50 mg

Color

Green

Size

13.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Narcotic analgesic combinations

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

4 - Some potential for abuse

Labeler / Supplier

Watson Pharmaceuticals

Inactive Ingredients

silicon dioxide, calcium phosphate dibasic anhydrous, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00591-0395	Watson Pharmaceuticals, Inc.
66267-0487	Nucare Pharmaceuticals Inc. (repackager)
63874-0220	Altura Pharmaceuticals Inc. (repackager)
43063-0142	PDRX Pharmaceuticals Inc. (repackager)
35356-0176	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer